ADVIA CENTAUR® CMV IGG
Mexico·Clase II·III. DIAGNOSTIC AGENTS·SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.·Registered July 17, 2019EL ENSAYO ADVIA CENTAUR® CMV IGG (CMV IGG) PARA LA DETERMINACIÓN CUALITATIVA Y SEMICUANTITATIVA DE ANTICUERPOS IGG FRENTE AL CITOMEGALOVIRUS (CMV) EN SUERO Y PLASMA HUMANO DE SUJETOS PEDIÁTRICOS Y ADULTOS (EDTA DIPOTÁSICO, HEPARINA DE LITIO) CON LOS SISTE
THE ADVIA CENTAUR® CMV IGG (CMV IGG) ASSAY FOR THE QUALITATIVE AND SEMI-QUANTITATIVE DETERMINATION OF IGG ANTIBODIES AGAINST CYTOMEGALOVIRUS (CMV) IN HUMAN SERUM AND PLASMA FROM PAEDIATRIC AND ADULT SUBJECTS (DIPOTASSIUM EDTA, LITHIUM HEPARIN) WITH SYSTEMS
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETECCIÓN DE ANTICUERPOS IGG FRENTE AL CITOMEGALOVIRUS
- Trade Name (English)
- CYTOMEGALOVIRUS IGG ANTIBODY ASSAY
- Analysis ID
- 1371R2019 SSA
- Registration Date
- July 17, 2019
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for ADVIA CENTAUR® CMV IGG (ADVIA CENTAUR® CMV IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1371R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on July 17, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.